References
- Mufti, G. J. and Grelton, D. A. G., Eds. (1992). The myelodysplastic syndromes, Churchill Livingstone, Edinburgh, London, Madris, Melbourne, New York, Tokyo.
- Kouides, P. A. and Bennett, J. M. (1996). Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Seminars in Hematology, 33, 95–110.
- Rosati, S., Anastase, J. and Vardiman, J. (1996). Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Seminars in Hematology, 33, 111–126.
- Verhoef, G. E. G. and Boogaerts, M. A. (1996). Cytogenetics and its prognostic value in myelodysplastic syndromes. Seminars in Hematology, 33, 95–101.
- Taichman, R. S. and Emerson, S. G. (1994). Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J. Exp. Med., 179, 1677–1682.
- Taichman, R. S., Reilly, M. J. and Emerson, S. G. (1996). Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood, 87, 518–524.
- Benayahu, D., Horowitz, M., Zipori, D. and Wientraub, S. (1992). Hematopoietic functions of marrow derived osteogenic cells. Calcif. Tissue. Int., 51, 195–201.
- Raza, A., Mundle, S., Shetty, V., Alvi, S., Chopra, H., Span, L., Parcharidou, A., Dar, S., Venugopal, P., Borok, R., Gezer, S., Showel, J., Loew, J., Robin, E., Rifkin, S., Alston, D., Hernandez, B., Shah, R., Kaizer, H., Gregory, S. and Preisler, H. (1996). A paradigm shift in myelodysplastic syndromes. Leukemia, 10, 1648–1652.
- MacDonald, B. R. and Gowen, M. (1992). Cytokines and bone. Br. J. Rheumatology, 31, 149–155.
- Duhrsen, U. and Hossfeld, D. K. (1996). Stromal abnormalities in neoplastic bone marrow diseases. Annals of Hematology, 73, 53–70.
- Raza, A., Gezer, S., Mundle, S., Gao, X.-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S. and Preisler, H. (1995). Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268–276.
- Cheng, S. L., Yang, J. W., Rifas, L., Zhang, S. F. and Avioli, L. V. (1994). Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology, 134, 277–289.
- Ohtsuki, T., Suzu, S., Nagata, N. and Motoyoshi, K. (1992). A human osteoblastic cell line MG-63 produces two molecular type of macrophage-colony-stimulating factor. Biochim. Biophys. Acta, 1136, 257–301.
- Mellibovsky, L., Diez, A., Serrano, S., Aubia, J., Perez-Vila, E., Marinoso, M. L., Nogues, X. and Recker, R. R. (1996). Bone remodelling alterations in myelodysplastic syndrome. Bone, 19, 401–405.